BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23670528)

  • 1. Differential gene expression in cholesteatoma by DNA chip analysis.
    Macias JD; Gerkin RD; Locke D; Macias MP
    Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased amphiregulin expression as a biomarker of cholesteatoma activity.
    Macias MP; Gerkin RD; Macias JD
    Laryngoscope; 2010 Nov; 120(11):2258-63. PubMed ID: 20938960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
    Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
    Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of gene expression profiles in cholesteatoma using oligonucleotide microarray.
    Kwon KH; Kim SJ; Kim HJ; Jung HH
    Acta Otolaryngol; 2006 Jul; 126(7):691-7. PubMed ID: 16803706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
    Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
    Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesteatoma growth and proliferation: relevance with serpin B3.
    Ho KY; Huang HH; Hung KF; Chen JC; Chai CY; Chen WT; Tsai SM; Chien CY; Wang HM; Wu YJ
    Laryngoscope; 2012 Dec; 122(12):2818-23. PubMed ID: 23239141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
    Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural changes and protein expression in the mastoid bone adjacent to cholesteatoma.
    Cinamon U; Kronenberg J; Benayahu D
    Laryngoscope; 2000 Jul; 110(7):1198-203. PubMed ID: 10892696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracrine loops of keratinocyte stimulation in cholesteatoma tissue: an immunofluorescence, transmission electron microscopy, and molecular study.
    d'Alessandro F; Raffa S; Murè C; Kovacs D; Torrisi MR; Barbara M
    Otol Neurotol; 2010 Sep; 31(7):1163-9. PubMed ID: 20679958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma.
    Hansen T; Unger RE; Gaumann A; Hundorf I; Maurer J; Kirkpatrick CJ; Kriegsmann J
    Mod Pathol; 2001 Dec; 14(12):1226-31. PubMed ID: 11743044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressions of caspase-14 in human middle ear cholesteatoma.
    Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
    Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray Analysis of Differentially-expressed MicroRNAs in Acquired Middle Ear Cholesteatoma.
    Xie S; Liu X; Pan Z; Chen X; Peng A; Yin T; Ren J; Liu W
    Int J Med Sci; 2018; 15(13):1547-1554. PubMed ID: 30443177
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of specific gene expression profiles in fibroblasts derived from middle ear cholesteatoma.
    Yoshikawa M; Kojima H; Wada K; Tsukidate T; Okada N; Saito H; Moriyama H
    Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):734-42. PubMed ID: 16847181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between human beta defensin expression and cholesteatoma formation.
    Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
    Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
    Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
    Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of placenta growth factor in human middle ear cholesteatoma.
    Cho JG; Lim HW; Woo JS; Hwang SJ; Lee HM; Chae SW
    Acta Otolaryngol; 2006 Sep; 126(9):900-4. PubMed ID: 16864484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of female sex hormone receptors in human middle-ear cholesteatomas.
    Raynov AM; Choung YH; Moon SK; Park K
    J Laryngol Otol; 2005 Dec; 119(12):941-5. PubMed ID: 16354354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression analysis of human middle ear cholesteatoma using complementary DNA arrays.
    Tokuriki M; Noda I; Saito T; Narita N; Sunaga H; Tsuzuki H; Ohtsubo T; Fujieda S; Saito H
    Laryngoscope; 2003 May; 113(5):808-14. PubMed ID: 12792315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiles of nasal polyps associated with allergic rhinitis.
    Wu J; Bing L; Jin H; Jingping F
    Am J Otolaryngol; 2009; 30(1):24-32. PubMed ID: 19027509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.